SFX by Ex Libris Inc.

Title:	Bioinorganic chemistry: a maturing frontier
Source:	Science [0036-8075] Lippard, S J yr:1993

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Zhang, C. "New metal complexes as potential therapeutics." Current opinion in chemical biology 7.4 (2003): 481-489.
description	2.	Baker, E N E. "Spectrochemical studies on the blue copper protein azurin from Alcaligenes denitrificans." Biochemistry 26.1: 71-82.
description	3.	Crane, J D. "Chapter 27. Bioinorganic chemistry." Annual reports on the progress of chemistry. Section A, Inorganic chemistry 92 (1995): 525-538.
description	4.	Sadler, Zijian J. "Metal complexes in medicine: Design and mechanism of action." Pure and applied chemistry 70.4 (1998): 863-871.
description	5.	Jamieson, E R R. "Structure, Recognition, and Processing of Cisplatin-DNA Adducts." Chemical reviews 99.9 (1999): 2467-98.
description	6.	Salvemini, D. "Reply to “Role of manganese superoxide dismutase in cancer”." Nature Medicine 9.9 (2003): 1103-.
description	7.	Jansen, B. "A tetranuclear platinum compound designed to overcome cisplatin resistance." European journal of inorganic chemistry 1999.9 (1999): 1429-1433.
description	8.	Cohen, Seth M. "Cisplatin: From DNA damage to cancer chemotherapy." Progress in Nucleic Acid Research and Molecular Biology 67 (2001): 93-130.
description	9.	ABRAMS, M J J. "METAL-COMPOUNDS IN THERAPY AND DIAGNOSIS." Science 261.5122 (1993): 725-730.
description	10.	Dismukes, G C. "Book Review: The Biological Chemistry of the Elements. By J. J. R. Frausto da Silva and R. J. P. Williams." Angewandte Chemie (International ed.) 41.11 (2002): 1966-.
description	11.	MIZOGUCHI, T. "BLUE TO TYPE-2 BINDING - COPPER(II) AND COBALT(II) DERIVATIVES OF A CYS112ASP MUTANT OF PSEUDOMONAS-AERUGINOSA AZURIN." Journal of the American Chemical Society 114.25 (1992): 10076-10078.
description	12.	Peleg-Shulman, T. "Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles." Journal of inorganic biochemistry 91.1 (2002): 306-311.
description	13.	Paraskevopoulos, K. "Active site structures and the redox properties of blue copper proteins: atomic resolution structure of azurin II and electronic structure calculations of azurin, plastocyanin and stellacyanin." Dalton transactions 25 (2006): 3067-3076.
description	14.	Rixe, O. "Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel." Biochemical Pharmacology 52.12 (1996): 1855-1865.
description	15.	KOPFMAIER, P. "COMPLEXES OF METALS OTHER THAN PLATINUM AS ANTITUMOR AGENTS." European journal of clinical pharmacology 47.1 (1994): 1-16.
description	16.	Hamamura, N. "Diversity in butane monooxygenases among butane-grown bacteria." Applied and environmental microbiology 65.10 (1999): 4586-4593.
description	17.	Yanagisawa, S. "Reduction potential tuning at a type 1 copper site does not compromise electron transfer reactivity." Journal of the American Chemical Society 127.47 (2005): 16453-16459.
description	18.	Clarke, Michael J. "Ruthenium metallopharmaceuticals." Coordination chemistry reviews 236.1 (2003): 209-93.
description	19.	Kainmueller, Eva a. "Synthesis of a new pair of fluorescence resonance energy transfer donor and acceptor dyes and its use in a protease assay." Chemical communications online 43 (2005): 5459-5461.
description	20.	Pil, Pieter M. "Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin." Science 256.5054 (1992): 234-237.